The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemiaLucy C. Fox, Andrew Grigg, Maciek Tatarczuch et al.|Blood Advances|2017Cited by 42
The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemiaAdrian Minson, Andrew Grigg, Katherine D. Cummins et al.|Blood Advances|2019Cited by 26
In silico and BSA binding study of some new biological analogs of 1,2,4-triazolependant with azinane through microwave and conventional synthesis.Naeem Akhtar Virk, Shafi Ullah Khan, Azizur Rehman et al.|PubMed|2018Cited by 1